Nebulised furosemide for the treatment of patients with obstructive lung disease: a systematic review protocol

INTRODUCTION: Obstructive lung diseases (OLDs) such as asthma and chronic obstructive pulmonary disease are major global sources of morbidity and mortality. Current treatments broadly include bronchodilators such as beta agonists/antimuscarinics and anti-inflammatory agents such as steroids. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Veldhoen, Richard, Muscedere, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668269/
https://www.ncbi.nlm.nih.gov/pubmed/37996224
http://dx.doi.org/10.1136/bmjopen-2022-070155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668269/
https://www.ncbi.nlm.nih.gov/pubmed/37996224
http://dx.doi.org/10.1136/bmjopen-2022-070155

Ejemplares similares